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ABSTRACT
Resveratrol, a polyphenolic phytoalexin found in many plants, was reported to exhibit anti-inflammatory effects, but its molecular 
mechanism is not fully understood. This study was aimed to investigate the anti-inflammatory effects of resveratrol in vivo using a 
zebrafish model of wound-induced inflammation. Caudal fin-wounded zebrafish larvae were treated with resveratrol for 8 h. Neutro-
phil recruitment was visualized in transgenic line “Tg (mpx：GFP)” expressing GFP-tagged neutrophil-speciﬁc myeloperoxidase (mpx). 
The enzymatic activity of Mpx was evaluated by histochemical staining. Relative mRNA levels of mpx and cyclooxegenase-2 (cox2) 
were quantified by qRT-PCR, and the protein expression levels of Mpx and Cox2 were detected by immunostaining. Results showed 
that wound-induced neutrophil recruitment in zebrafish was not affected by resveratrol, but Mpx enzymatic activity in zebrafish was 
significantly suppressed by resveratrol in a dose-dependent manner. Moreover, both mRNA and protein expression levels of Mpx and 
Cox2 were significantly down-regulated by resveratrol. Taken together, our results provide in vivo evidence that the anti-inflammatory 
effects of resveratrol on wound-induced inflammation are significantly mediated through the suppression of Mpx and Cox2 at both 
transcriptional and protein levels, rather than the down-regulation of neutrophil recruitment. In conclusion, this in vivo zebrafish model 
can be readily applied to screen other potential anti-inflammatory compounds at a whole-organism level.
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INTRODUCTION
The wound-induced inflammation involves dynamic 
regulation of pro-inflammatory mediators and enzymes 
accompanying the recruitment of blood cells to wound sites. 
Circulating leukocytes are the key cells, and the chemotaxis 
of neutrophils to sites of inflammation is essential for physi-
ological responses to tissue injury and infection(1). However, 
dysregulated or excessive inflammation may lead to patho-
logical consequences. To attenuate potential adverse effects 
of wound-induced inflammation, it is essential to identify or 
develop effective anti-inflammatory compounds.
Resveratrol (trans-3,4’,-5-trihydroxystilebene, Figure 1A) 
is a natural polyphenolic phytoalexin found in many plants. 
Resveratrol has been reported to exhibit anti-inflammatory 
activity through down-regulation of the inflammatory 
responses, but the molecular mechanism is not fully under-
stood. In isolated leukocytes of mice or human cell lines, 
resveratrol has been reported to inhibit pro-inflammatory 
mediators and enzymes, such as Cox2, TNF-induced acti-
vation of nuclear transcription factors NF-κB, and NF-κB-
dependent gene expression(2-5). In isolated neutrophils of 
turbot (Psetta maxima), resveratrol is shown to inhibit the 
activity and transcription of mpx gene(6). However, current 
knowledge regarding the anti-inflammatory effects of resve-
ratrol in vertebrates has been reported in vitro. Thus, it is 
essential to establish an effective animal model to study the 
in vivo anti-inflammatory effects of resveratrol.
Zebraﬁsh is a widely used model organism because of 
its morphological and physiological similarity to mammals, 
and the optical transparency of zebraﬁsh embryos allows 
noninvasive and dynamic imaging the inflammation in 
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vivo. The innate immunity of vertebrates is evolutionarily 
conserved from zebraﬁsh to mammals. Zebraﬁsh embryos 
develop several immune cells homologous to mammalian 
counterparts, and the innate immunity of zebraﬁsh even 
appears highly evolved with potentially enhanced function-
ality in comparison to those of mammals(7,8). Neutrophils 
are the most abundant leukocytes in adult zebraﬁsh, and 
myeloperoxidase (Mpx) is an abundant peroxidase speciﬁ-
cally expressed in zebraﬁsh neutrophils(7). Zebraﬁsh mpx 
gene is expressed in embryos from 18 hpf on, thus neutro-
phil recruitment in zebraﬁsh can be observed using mpx as a 
neutrophil marker(9,10). In addition to Mpx, cyclooxygenase2 
(Cox2) is an inducible inflammatory enzyme catalyzing the 
rate-limiting step in prostaglandin synthesis in response to 
inflammation. Zebraﬁsh cox2 gene is genetically and func-
tionally homologous to its mammalian orthologs(11,12). 
In this study, a wounded zebraﬁsh model was used to 
assess the anti-inflammatory effects of resveratrol on wound-
induced inflammation in vivo. We observed a transgenic 
zebraﬁsh line Tg (mpx：GFP) expressing green fluorescent 
protein (GFP) under the control of neutrophil-speciﬁc mpx 
promoter(13) to visualize the recruitment of neutrophils to 
wounded sites. We also evaluated the Mpx expression by 
histochemical staining(14), and examined the transcriptional 
and protein levels of two evolutionarily conserved pro-inflam-
matory enzymes (Mpx and Cox2) upon resveratrol treatment.
MATERIALS AND METHODS
I. Zebrafish Larvae, Fin Amputation and Resveratrol 
Treatment
Zebraﬁsh larvae (wild-type, WT; AB strain) and Tg 
(mpx：GFP)(13) were raised at 28.5°C and staged according 
to standard protocols(15,16). All larvae were grown in 0.003% 
N-phenylthiourea (PTU, Sigma-Aldrich) to suppress melani-
zation. To trigger wound-induced inflammation, caudal ﬁn 
of zebraﬁsh larvae at 72 hours post-fertilization (hpf) was 
half-amputated, around 50% of caudal ﬁn area was removed 
(Figure 1A). To make wounds as consistently sized as 
possible, ﬁn amputation (FA) was performed using a cryostat 
blade under a dissecting microscope.
Resveratrol (C14H12O3, Sigma-Aldrich) was dissolved 
in dimethylsulfoxide (DMSO) as stock solution (2,500 
ppm), and diluted to desired concentrations for treatment. 
Unwounded zebraﬁsh larvae (FA-) were randomly divided 
into “blank” group (FA-, RESV-) and “resv” group (FA-, 
Figure 1. Myeloperoxidase (Mpx) expression in zebraﬁsh larvae in response to wounding or resveratrol treatment. (A) Experimental scheme 
for detecting Mpx expression in zebrafish larvae. (B-D) The distribution of neutrophils in living Tg(mpx：GFP) zebrafish larvae using GFP 
fluorescence as a marker. Dashed line outlines the region of caudal fin. (E) Comparison of Mpx：GFP-expressing cells among groups (B-D). 
(F-H) The endogenous myeloperoxidase (Mpx) activity in wild-type zebraﬁsh larvae. (I) Comparison of Mpx enzymatic activity among groups 
(F-H). Abbreviations: FA, fin amputation; Resv, resveratrol; Blank, unwounded group; Control, wounded group without treatment; Treated, 
wounded group treated with 25 ppm of resveratrol.
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RESV+), whereas wounded larvae (FA+) for no-treatment 
“control” group (FA+, RESV-) or resveratrol-“treated” group 
(FA+, RESV+). Each group was exposed to DMSO (RESV-) 
or resveratrol (RESV+) in the dark at 28.5°C for 8 hours 
(Figure 1A). The ﬁnal concentration of DMSO used in all 
groups was less than 1%. The possible effects of DMSO 
(1%) could be neglected because the same amount of vehicle 
solvent was applied to all groups.
II. Myeloperoxidase Staining
Myeloperoxidase staining of zebraﬁsh larvae was based 
on the method of Kaplow(14). Larvae at 72 hpf were ﬁxed with 
10% formaldehyde/ethanol at room temperature for 1 min. 
After washing with double-distilled water (ddH2O) for 30 s, 
myeloperoxidase (Mpx) of larvae was stained with incuba-
tion mixture (30% ethanol, 0.3% benzidine dihydrochloride, 
0.38% ZnSO4•7H2O, 1% sodium acetate, 0.02% H2O2, 
0.015N NaOH, pH 6) at room temperature for 5 - 10 min, 
and stopped by washing with ddH2O for 30 s. After staining, 
Mpx-stain (+) cells were shown in brown.
III. Quantitative Reverse Transcription-Polymerase Chain 
Reaction (qRT-PCR)
Total RNAs were extracted from zebraﬁsh and reverse-
transcribed by the standard procedure as described previ-
ously(17,18). Gene-speciﬁc PCR primer sequences were listed 
in Table 1. Quantitative PCR was performed for 2 min at 
50°C, 10 min at 95°C, and 40 cycles of 15 s at 95°C, and 1 
min at 60°C, using 2X Power SYBR Green PCR Master Mix 
(Applied Biosystems) and 200 nM of forward and reverse 
primers (Table 1). Each assay was performed in triplicates 
on an Applied Biosystems 7300 Real-Time PCR system, and 
expression fold-changes were derived by the comparative CT 
method. The β-actin mRNA was used as an internal control 
for relative quantiﬁcation.
IV. Whole-Mount Immunostaining
Whole-mount immunostaining was performed as previ-
ously described, with minor modiﬁcations(19). Expression 
levels of Mpx and Cox2 were detected with rabbit polyclonal 
primary antibodies against either Mpx (1 : 20; AnaSpec) or 
Cox2 (1 : 10; Cayman Chemicals), and visualized with Alexa 
Fluor 568-conjugated goat-anti-rabbit IgG (1 : 200; Invit-
rogen) as the secondary antibody.
V. Image Acquisition and Analysis
Images were acquired using a camera (Leica DFC 280) 
attached to a stereomicroscope (Leica DM 2500; objective: 
20x; ﬁlter: for GFP or RFP fluorescence). Acquired images 
were analyzed by using built-in functions (“Analyze Particles” 
and “Find Maxima” for automated counting; “Cell Counter” 
for manual counting) of ImageJ (NIH Image software). Results 
from automated counting were conﬁrmed in consistency with 
those from manual counting. To quantify the relative intensity 
of immunostaining images, each image was transformed into 
grayscale format and analyzed by using Igor Pro software 
(WaveMetrics) to compute the value of “Intensity(mean/max)“, 
i.e. average intensity normalized to the maximum..
VI. Statistical Analysis
Quantitative data were expressed as mean ± SEM (stan-
dard error of the mean). Statistical signiﬁcance was deter-
mined by two-sample t-test. p-value of less than 0.05 was 
considered statistically signiﬁcant.
RESULTS
I. Zebrafish Model of Wound-Induced Inflammation
To investigate wound-induced inflammation in vivo, we 
used transgenic zebraﬁsh Tg (mpx：GFP) expressing GFP-
tagged neutrophils which has been used to visualize the reso-
lution of inflammation(1,10,20,21). Because the inflammatory 
response to wounding depends on the wound size, we half-
amputated caudal ﬁn of zebraﬁsh (Figure 1A) to obtain rela-
tively consistent wound sizes and inflammatory responses in 
comparison with those by tip amputation(1,20) and complete 
transaction of caudal ﬁn(10,21).
Green fluorescent neutrophils (hereafter cited as Mpx: 
GFP(+) cells) were observed during wound-induced inflam-
mation (Figure 1B-E). In unwounded zebraﬁsh, Mpx: GFP(+) 
cells were observed within the blood circulation (Figure 1B, 
Blank). In contrast, circulating Mpx: GFP(+) cells tended 
to migrate toward the wound site upon ﬁn amputation in 
wounded zebraﬁsh (Figure 1C, Control). A signiﬁcant 
increase in Mpx: GFP(+) cells was observed in the wounded 
group (Figure 1E, Control, Mpx: GFP(+): 17 ± 2, n = 17) 
compared with the unwounded group (Figure 1E, Blank, 
Mpx: GFP(+): 2.6 ± 1.6, n = 5), demonstrating a wound-
induced recruitment of Mpx: GFP-expressing neutrophils 
similar to previous studies(1,10,20,21).
II. Effects of Resveratrol on Wound-Induced Neutrophil 
Recruitment and Mpx Enzymatic Activity
Upon treatment with 25 ppm of resveratrol for 8 h, the 
Table 1. Primers used in this study
Primer Sequence (5’ → 3’)
β-actin-F CAGCAAGCAGGAGTACGATGAGT
β-actin-R TTGAATCTCATTGCTAGGCCATT
Danio cox2-F CTGCACTCTTGAGCTGTTCCAT
Danio cox2-R AGAATACACCTGGACGTGAAACAA
Danio mpx-F GAGCTCCTGCCCTTTACTAGTGTT
Danio mpx -R TCACCCGCAATGAAGCAA
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wound-induced neutrophil recruitment was slightly attenu-
ated in the resveratrol-treated group (Figure 1D, Treated). 
However, the difference between resveratrol-treated group 
(Figure 1E, Treated, Mpx：GFP(+): 16 ± 4.5, n = 8) and 
no-treatment control (Figure 1E, Control) was not statisti-
cally signiﬁcant (Figure 1E, Treated versus Control, p > 
0.05). These in vivo results preliminarily demonstrated that 
wound-induced neutrophil recruitment in living zebraﬁsh 
was not affected by resveratrol treatment. 
To further evaluate the effect of resveratrol treatment 
on Mpx enzymatic activity in neutrophils, endogenous Mpx 
enzymatic activity in wild-type zebraﬁsh was observed by 
histochemical staining with peroxidase substrate benzidine 
(Figure 1F-I). Positively-stained cells (hereafter cited as 
Mpx(+) cells) revealed the Mpx activities in vivo and in situ. 
Based on the Mpx(+) cells observed in the tailﬁn region, 
wounded zebraﬁsh (Figure 1G, Control, Mpx(+): 30 ± 3, n = 32) 
revealed a signiﬁcant increase in Mpx enzymatic activity 
(Figure 1I, p < 0.05) versus the corresponding blank group 
(Figure 1F, Blank, Mpx(+): 2.8 ± 0.47, n = 24). Upon resve-
ratrol treatment, a signiﬁcant decrease (Figure 1I, p < 0.05) 
of the Mpx(+) cells was observed in resveratrol-treated 
group (Figure 1H, Treated, Mpx(+): 17 ± 3.8; n = 25) versus 
no-treatment control (Figure 1G, Control). Taken together, 
resveratrol signiﬁcantly attenuated the Mpx enzymatic 
activity (Figure 1I), rather than the wound-induced neutro-
phil recruitment in vivo (Figure 1E).
III. Dose-Dependent Attenuation of Mpx Enzymatic Activity 
by Resveratrol
The dose-dependency of the Mpx enzymatic activity 
on resveratrol treatment was further examined by exposing 
wounded zebraﬁsh larvae at 72 hpf to different doses of resve-
ratrol (0, 5, 10, and 25 ppm, respectively) for 8 h (Figure 2). 
In the absence of resveratrol treatment (0 ppm), Mpx(+)-cells 
were widely distributed around wounded sites (Figure 2A). 
Upon treatment with 25 ppm of resveratrol, Mpx(+)-cells 
were signiﬁcantly reduced (Figure 2D). With increasing 
resveratrol doses (5 ppm, 10 ppm, and 25 ppm), there was a 
tendency towards reduction in Mpx(+)-cells in the caudal ﬁn 
region of wounded zebraﬁsh larvae (Figure 2B-D), suggesting 
that resveratrol attenuated Mpx enzymatic activity in a dose-
dependent manner. 
(A)
(C)
(B)
(D)
Figure 2. Dose-dependent suppression of the Mpx-positive cells in wounded zebrafish larvae upon resveratrol treatment. (A) No-treatment 
control (0 ppm) and (B-D) resveratrol-treated groups (B, 5 ppm; C, 10 ppm; and D, 25 ppm).
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IV. Molecular Mechanism of Anti-Inflammatory Effects of 
Resveratrol
To further investigate the molecular mechanism of anti-
inflammatory effects of resveratrol, we examined the effects 
of resveratrol on Mpx and Cox2 at transcriptional and protein 
levels (Figure 3). The relative mRNA expression levels of 
mpx and cox2 in zebraﬁsh larvae at 80-hpf were quantiﬁed 
by qRT-PCR assays (Figure 3, A-B). Figure 3A shows the 
transcriptional levels of mpx relative to control group. Blank 
group (1 ± 0.19) and Resv group (0.76 ± 0.11) showed compa-
rable levels to the control group (1 ± 0.21), whereas resvera-
trol-treated group showed signiﬁcant decrease (0.13 ± 0.03, 
p < 0.05) compared with no-treatment control group. These 
results showed that resveratrol attenuated the mRNA expres-
sion of mpx, correlated well with above-mentioned results 
revealed by transgenic line (Figure 1B-E, Mpx：GFP(+) 
cells). Similarly, Figure 3B presents the transcriptional levels 
of cox2 relative to control group. Blank group (0.78 ± 0.27) 
and Resv group (0.84 ± 0.05) showed comparable levels to the 
control group (1 ± 0.07), whereas resveratrol-treated group 
showed signiﬁcant decrease (0.64 ± 0.08, p < 0.05) compared 
with no-treatment control group. These results revealed that 
resveratrol suppressed the transcriptional levels of mpx and 
cox2 in wound-induced inflammation.
Moreover, the effects of resveratrol on Mpx and Cox2 
at protein level were also examined. The protein expression 
levels of Mpx and Cox2 in zebraﬁsh larvae at 80-hpf (8 h 
post-treatment) were detected by whole-mount immunos-
taining using antibodies against Mpx or Cox2 (Figure 3, 
C-D). Figure 3C shows the relative protein expression levels 
of Mpx in the caudal-fin region. In unwounded groups, Mpx 
Figure 3. Effects of resveratrol on myeloperoxidase (Mpx) and cyclooxygenase-2 (Cox2) in 80-hpf zebrafish larvae at transcriptional and 
protein levels. (A-B) Relative mRNA expression levels of mpx (A) and cox2 (B) using the comparative CT method (CT: cycles of qPCR; 
a: Rela-
tive folds to control group =2−ΔΔCT; b: The resveratrol-treated group is signiﬁcantly different from control group). (C-D) Whole-mount immu-
nostaining of zebraﬁsh larvae with antibodies against Mpx (C) and Cox2 (D). Dashed lines outline the region of caudal ﬁn, and arrows indicate 
the wounded sites. Abbreviations: Blank, unwounded group; Resv, unwounded group treated with resveratrol (25 ppm); Control, wounded 
group; Treated, wounded group treated with resveratrol (25 ppm).
(A) (B)
(C) (D)
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expression was detected in blood circulation, but did not 
appear in the caudal-fin region (Figure 3C, Blank and Resv). 
After ﬁn amputation, Mpx expression in wounded groups 
was observed around the wounded sites (indicated by arrows 
in Figure 3C, Control and Treated). Upon resveratrol treat-
ment, Mpx expression in resveratrol-treated group (Figure 
3C, Treated) appeared to decrease compared with no-treat-
ment control group (Figure 3C, Control). These immunos-
taining results revealed that resveratrol attenuated the protein 
expression of Mpx in wound-induced inflammation, not only 
consistent with above-mentioned transcriptional levels of 
mpx (Figure 3A) but correlated well with above-mentioned 
Mpx enzymatic activity revealed by histochemical staining 
(Figure 1F-I, Mpx(+) cells).
On the other hand, Figure 3D presents the relative 
protein expression levels of Cox2 in the caudal-ﬁn region. 
In unwounded groups, Cox2 expression did not appear in 
the caudal-ﬁn region (Figure 3D, Blank and Resv). After ﬁn 
amputation, Cox2 expression in wounded groups was induced 
around the wounded sites (indicated by arrows in Figure 3D, 
Control and Treated). Upon resveratrol treatment, Cox2 
expression in resveratrol-treated group (Figure 3D, Treated) 
appeared to decrease compared with no-treatment control 
group (Figure 3D, Control). These immunostaining results 
indicated that resveratrol attenuated the protein expression of 
Cox2 in wound-induced inflammation, correlated well with 
above-mentioned transcriptional levels of cox2 (Figure 3B). 
Taken together, our results suggested that the anti-inflamma-
tory effects of resveratrol on wound-induced inflammation 
were mediated through the suppression of Mpx and Cox2 
expression at both transcriptional and protein levels. In addi-
tion, the effects of resveratrol on the suppression of Mpx were 
more signiﬁcant than those on the suppression of Cox2.
DISCUSSION
This study demonstrated that the anti-inflammatory 
effects of resveratrol on wound-induced inflammation 
are mediated through the suppression of Mpx and Cox2 
expression at both transcriptional and protein levels. To our 
knowledge this is the ﬁrst in vivo evidence that resveratrol 
attenuates the wound-induced inflammation through Mpx 
and Cox2 at a whole-organism level. Our in vivo evidence is 
also consistent with previous in vitro one from cell-based or 
enzyme-based assays in other vertebrate models of inflam-
mation. For example, resveratrol was reported to decrease 
Mpx enzymatic activity and COX-2 expression level in 
isolated leukocytes of rats(22). Resveratrol has been demon-
strated to inhibit transcription and enzymatic activity of 
myeloperoxidase in isolated neutrophils of human and other 
species(6,23,24). Resveratrol was also revealed to inhibit Cox2 
transcription and activity in phorbol ester-treated human 
mammary epithelial cells(3). Resveratrol has been reported 
to affect several signal transduction pathways (e.g. TNF-α, 
MAPKs, NF-κB, and so on)(25,26). Whether these signaling 
mechanisms are directly or indirectly involved in the 
anti-inflammatory effects of resveratrol on Mpx and Cox2 
needs further investigation.
Based on partial ﬁn amputation used in this study to 
yield relatively consistent wound sizes and inflammatory 
responses, this zebraﬁsh model of wound-induced inflamma-
tion could be used for better understanding of the resolution 
of wound-induced inflammation and wound-healing process. 
Moreover, this zebraﬁsh model of wound-induced inflam-
mation can also be readily applied to in vivo screening of 
the therapeutic potential of anti-inflammatory compounds, 
which are worth further tests in higher vertebrates. Further-
more, an automated screening platform of zebraﬁsh larvae in 
high throughput was reported to process a single zebraﬁsh 
larva in less than 30 seconds(27), demonstrating that zebraﬁsh 
is emerging as a powerful platform for genetic and chemical 
screening at a whole-organism level.
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